| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -10.8% |
| Cost of Revenue | $1.6M | -0.8% |
| Gross Profit | $596K | -29.6% |
| R&D Expense | $0 | — |
| SG&A Expense | $612K | -23.3% |
| Operating Income | -$2.6M | +17.8% |
| Pre-tax Income | -$6.8M | -54.2% |
| Net Income | -$6.8M | -54.2% |
| EPS (Basic) | -$1.55 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $602K | +870.1% |
| Accounts Receivable | $398K | +0.0% |
| Inventory | $470K | -5.4% |
| Current Assets | $6.3M | +95.6% |
| Total Assets | $12.4M | +30.6% |
| Current Liabilities | $6.0M | -6.9% |
| Total Liabilities | $6.2M | -6.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | -122.5% |
| Capital Expenditures | $13K | — |
| Investing Cash Flow | $246K | +52.4% |
| Financing Cash Flow | $8.2M | +143.5% |
| Free Cash Flow | -$7.9M | — |
| -1450.0% |
| EPS (Diluted) | -$1.55 | -1450.0% |
| Stockholders' Equity |
| $6.2M |
| +112.6% |